Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avian ("Bird") Flu Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Rascal who wrote (327)	1/24/2006 11:25:20 AM
From: Hawkmoon	Respond to of 428

Basically followed it due to their oral diabetes drug since PFE just paid some big bucks for a rival inhaled diabetes drug (GNBT is strictly mouth.. "Buccal"). But I had also read that one of their subsidiaries, Antigen, was working on a drug that would enhance the effectiveness of Avian Flu virus drugs. And since their drug is able to be manufactured synthetically, it would be able to be mass-produced. So.. no real special insight.. Just TechAnal and watching the volume and news. It's in consolidation now after yesterday's big move. But I hope were short-term oversold at 1.10 and ready for a move back up. That's a 3/4 retracement from yesterday's high so the Fibonacci whatchamacallit appears to indicate support. We'll see. It's definitely a stock to watch, considering the major volatility and percentage gains that have occurred. Hawk